Business
Grant of share options to Director and employees
Grant of share options to Director and employees.
About this update from Transense Technologies Plc
[{"type":"text","content":"\n \n \n \n Transense Technologies plc\n \n \n \n (\"Transense\", or \"the Company\")\n \n \n \n \n \n \n \n \n Grant of share options to Director and employees\n \n \n \n \n \n \n \n \n Transense Technologies plc (AIM: TRT), the provider of specialist sensor systems, announces that it has today granted 200,000 options to acquire ordinary shares in the Company to employees and a Director (the \"Options\").\n \n \n In accordance with the Company's share scheme, the Options have an exercise price at nominal value of 10 pence per share and can be exercised after three years until the tenth anniversary of the grant. Two thirds of the options are only exercisable if the Company's share price exceeds 150 pence per share for ten consecutive trading days at any time. The remaining one third are only exercisable in full if the share price exceeds 200 pence per share for ten consecutive trading days at any time, with none of this tranche being exercisable if the share price has not exceeded 150 pence per share for ten consecutive trading days and a pro-rata amount will be exercisable between these two share price targets.\n \n \n Since the last audited financial statements of the Company, for the year ended 30 June 2022, a total of 332,000 options have lapsed. Accordingly, following this announcement there are 1,462,500 unexercised share options over ordinary shares in issue, representing approximately 8.90% of the current issued share capital of the Company.\n \n \n Included in the above grant of options are 100,000 options granted to Ryan Maughan, a director of the Company, taking his total unexercised share options to 150,000.\n \n \n For further information please visit www.transense.com or contact:\n \n \n \n \n \n \n Transense Technologies plc\n \n \n Nigel Rogers (Executive Chairman)\n \n \n Melvyn Segal (CFO)\n \n \n \n \n Via Walbrook PR\n \n \n \n \n \n \n Allenby Capital (Nominated Adviser and Broker)\n \n \n Jeremy Porter/George Payne (Corporate Finance)\n \n \n Tony Quirke/Jos Pinnington (Sales & Corporate Broking)\n \n \n \n \n Tel: +44 (0)20 3328 5656\n \n \n \n \n \n \n Walbrook PR\n \n \n Tom Cooper/Nick Rome / Joseph Walker\n \n \n \n \n Tel: +44 (0)20 7933 8780\n \n \n [email protected]\n \n \n \n \n \n \n \n \n \n Notes to Editors:\n \n \n Transense is a developer of specialist wirele...